Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Open in API
Filings indexed 613 across all filing types
Latest filing 2022-09-07 Board/Management Inform…
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Optomedin osakkeenomistajien nimitystoimikunta
Board/Management Information Classification · 95% confidence The document is a stock exchange release (Pörssitiedote) announcing the composition of the company's shareholders' nomination committee. It details the members appointed by the largest shareholders and the committee's purpose in preparing proposals for the next general meeting. As this relates to corporate governance and board composition processes rather than a specific financial report, dividend, or transaction, it falls under the general regulatory announcement category.
2022-09-07 Finnish
Composition of Optomed's Nomination Board
Governance Information Classification · 95% confidence The document is a 'Stock Exchange Release' from Optomed Plc dated September 7, 2022, announcing the 'Composition of Optomed's Nomination Board'. It details which shareholders are represented and who they have appointed to the board. The Nomination Board's function is explicitly stated: 'to prepare proposals on the composition and members of the Board of Directors and their remuneration for the next Annual General Meeting'. This content directly relates to the governance structure, board composition, and preparation for shareholder meetings, which falls under Governance Information (CGR) or potentially Board/Management Information (MANG). Since it specifically details the structure and process related to the Board's composition and remuneration proposals for the AGM, CGR (Governance Information) is the most precise fit, as it covers internal rules and board structure details. It is not a general regulatory filing (RNS) because it is highly specific to corporate governance.
2022-09-07 English
Optomedin osakkeenomistajien nimitystoimikunta
Board/Management Information Classification · 99% confidence The document is a short press release (Pörssitiedote) from Optomed Oyj, dated September 7, 2022. The content specifically discusses the composition and function of the 'Shareholders' Nomination Committee' (osakkeenomistajien nimitystoimikunta), which prepares proposals for the composition and remuneration of the Board of Directors for the next general meeting. This topic directly relates to corporate governance, board structure, and the process for nominating directors. This aligns best with the 'Governance Information' category (CGR), which covers internal rules, board structure, and governance practices. It is not an earnings release (ER), a formal annual report (10-K), or a management change announcement (MANG), but rather a procedural announcement about a key governance body.
2022-09-07 Finnish
Optomedin ylimääräisen yhtiökokouksen päätökset
Board/Management Information Classification · 98% confidence The document is an announcement regarding the decisions made at an Extraordinary General Meeting (ylimääräinen yhtiökokous) of Optomed Oyj. It specifically details the election of a new board member, Mars Duan, and lists the updated composition of the Board of Directors. Since it reports the outcome of a shareholder meeting, it falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2022-09-06 Finnish
Decisions of Optomed's Extraordinary General Meeting
Board/Management Information Classification · 95% confidence The document is a short stock exchange release announcing the decisions made at an Extraordinary General Meeting, specifically the election of a new board member. While it relates to a meeting, it is not a full presentation (AGM-R) or a proxy statement (PSI). It focuses on the outcome of the meeting regarding board composition, which fits the definition of a board-related announcement, but since it specifically reports the results of a general meeting vote/decision, it is best classified as a Declaration of Voting Results (DVA).
2022-09-06 English
08161083.pdf
Share Issue/Capital Change Classification · 95% confidence The document is a formal legal text outlining the terms and conditions of a stock option plan (2022A) for Optomed Oyj. It details the issuance, allocation, subscription periods, pricing, and rights of option holders. This type of document is a corporate governance and compensation-related disclosure, which falls under the category of Proxy Solicitation & Information Statement (PSI) as it relates to shareholder-approved incentive plans and the specific terms governing them.
2022-08-16 Finnish

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.